Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. (Q53344716)

13 May 2018

title

Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. (English)

1 reference

13 May 2018

1 reference

Gábor Sobel

1

1 reference

13 May 2018

Júlia Németh

2

1 reference

13 May 2018

András Kiss

3

1 reference

13 May 2018

Gabor Lotz

4

1 reference

13 May 2018

István Szabó

5

1 reference

13 May 2018

Nóra Udvarhelyi

6

1 reference

13 May 2018

Zsuzsa Schaff

7

1 reference

13 May 2018

Csilla Páska

8

1 reference

13 May 2018

language of work or name

English

0 references

publication date

22 June 2006

1 reference

13 May 2018

published in

Gynecologic Oncology

1 reference

13 May 2018

volume

103

1 reference

13 May 2018

page(s)

591-598

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Progesterone receptor isoform identification and subcellular localization in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Uterine papillary serous carcinoma: what have we learned over the past quarter century?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Molecular pathology of endometrial hyperplasia and carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Manner of interaction of heterogeneous claudin species within and between tight junction strands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin proteins in human cancer: promising new targets for diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin expression in Barrett's esophagus and adenocarcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

7 January 2021

Tight junction proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Embryonic signals direct the formation of tight junctional permeability barrier in the decidualizing stroma during embryo implantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Barriers built on claudins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Increased tight junctional permeability is associated with the development of colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudins upregulation in human colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Gene identification by cDNA arrays in HPV-positive cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

beta-catenin and its regulatory network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Cloning of the human claudin-2 5'-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-1 contributes to the epithelial barrier function in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Role of claudins in tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.04.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.04.005

1 reference

13 May 2018

PubMed ID

16797678

1 reference

13 May 2018